Clinical observations have shown that the pharmacological effect of bevacizumab to handle retinal diseases is as safe and effective as to other anti-VEGF agents (Berg et al., 2015; Martin et al., 2020; Plyukhova et al., 2020). Here, VEGFA is linked to Abnormal retinal morphology.